Source: Scientific Reports. Unidades: IFSC, IQ
Subjects: NEOPLASIAS DE CABEÇA E PESCOÇO, CRÂNIO, PEDIATRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PAVON, Lorena Favaro et al. New therapeutic target for pediatric anaplastic ependymoma control: study of anti-tumor activity by a Kunitz-type molecule, Amblyomin-X. Scientific Reports, v. 9, p. 9973-1-9973-10, 2019Tradução . . Disponível em: https://doi.org/10.1038/s41598-019-45799-4. Acesso em: 07 nov. 2024.APA
Pavon, L. F., Capper, D., Sibov, T. T., Toledo, S. R. C. de, Thomale, U. -W., Souza, J. G. de, et al. (2019). New therapeutic target for pediatric anaplastic ependymoma control: study of anti-tumor activity by a Kunitz-type molecule, Amblyomin-X. Scientific Reports, 9, 9973-1-9973-10. doi:10.1038/s41598-019-45799-4NLM
Pavon LF, Capper D, Sibov TT, Toledo SRC de, Thomale U-W, Souza JG de, Cabral FR, Berra CM, Costa MDS da, Niçacio JM, Dastoli PA, Oliveira DM de, Malheiros SMF, Cruz EF da, Malheiros JM, Mascarenhas S, Silva NS, Petrilli AS, Capellano AM, Brunialti MC, Salomão R, Paiva Neto MA, Chudzinski-Tavassi AM, Cavalheiro S. New therapeutic target for pediatric anaplastic ependymoma control: study of anti-tumor activity by a Kunitz-type molecule, Amblyomin-X [Internet]. Scientific Reports. 2019 ; 9 9973-1-9973-10.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1038/s41598-019-45799-4Vancouver
Pavon LF, Capper D, Sibov TT, Toledo SRC de, Thomale U-W, Souza JG de, Cabral FR, Berra CM, Costa MDS da, Niçacio JM, Dastoli PA, Oliveira DM de, Malheiros SMF, Cruz EF da, Malheiros JM, Mascarenhas S, Silva NS, Petrilli AS, Capellano AM, Brunialti MC, Salomão R, Paiva Neto MA, Chudzinski-Tavassi AM, Cavalheiro S. New therapeutic target for pediatric anaplastic ependymoma control: study of anti-tumor activity by a Kunitz-type molecule, Amblyomin-X [Internet]. Scientific Reports. 2019 ; 9 9973-1-9973-10.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1038/s41598-019-45799-4
